Zhilong Yuan

Design and Sample Size Considerations for Simultaneous Global Drug Development Program

K. K. Gordon Lan, Qin Huang, Gang Chen, 2012, Journal of biopharmaceutical statistics.

Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthracycline therapy: results from a randomized phase II

Liang Xiu, N. Bogdanova, J. Sparano, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isotonic designs for phase I cancer clinical trials with multiple risk groups

Zhilong Yuan, Zhilong Yuan, Rick Chappellb, 2004, Clinical trials.